Guo Hua-bei , B. Stoffel-Wagner , W. Brennemann , W. Springer , D. Klingmüller

Current Medical Science ›› 1995, Vol. 15 ›› Issue (1) : 19 -25.

PDF
Current Medical Science ›› 1995, Vol. 15 ›› Issue (1) :19 -25. DOI: 10.1007/BF02887879

Author information +
History +
PDF

Cite this article

Download citation ▾
Guo Hua-bei, B. Stoffel-Wagner, W. Brennemann, W. Springer, D. Klingmüller. . Current Medical Science, 1995, 15(1): 19-25 DOI:10.1007/BF02887879

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

HoffmanS J, YohnJ J, NorrisD A, et al.. Cutaneous malignant melanoma. Curr Probl Dermatol, 1993, 5: 1-1

[2]

KohH K. Cutaneous melanoma. N Engl J Med, 1991, 325: 171-171

[3]

RyanL, KramarA, BordenE. Prognostic factors in metastastic melanoma. Cancer, 1993, 71: 2995-2995

[4]

MarangosP J, Zomzely-NeurathC. Determination and characterization of neuron specific protein (NSP) associated enolase activity. Biochem Biophys Res Commun, 1976, 68: 1309-1309

[5]

MarangosP J, SchmechelD, ParmaAm, et al.. Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue. J Neurochim, 1979, 33: 319-319

[6]

ZeltzerP M, MarangosP J, EvansA E, et al.. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and diseae course. Cancer, 1986, 57: 1230-1230

[7]

FischbachW, Schwarz-WallrauchC, JanyB. Neuron-specific enolase and thymidin kinae as an aid to the diagnosis and treatment monitoring of small cell lung cancer. Cancer, 1989, 63: 1143-1143

[8]

JoergensenL G M, OesterlindK, HansenH, et al.. The prognostic influence of serum neuronspecific enolase in small cell lung cancer. Br J Cancer, 1988, 58: 805-805

[9]

UerlichM, BlitzH, KreyselH W. Neuronspezifische Enolase und β2-Microglobulin im Serum von Melanompatienten. Immun Infekt, 1988, 16: 65-65

[10]

MachensH G, Schmidt-GaykH, MathiasD, et al.. Neuron-specific enolase (NSE) -A serum marker for malignant melanoma?. Klapdor R ed. Tumor associated antigens, oncogens, receptors, cytokines in tumor diagnosis and therapy at the beginning of the nineties, 1992München, Bern, Wien, New YorkW. Zuckschwerdt Verlag194-197

[11]

WibeE, PausE, AamdalS. Neuron specific enolase (NSE) in serum of patients with malignant melanoma. Cancer Lett, 1990, 52: 29-29

[12]

WibeE, HannisdalE, PausE, et al.. Neuronspecific enolase as a prognostic factor in metastastic malignant melanoma. Eur J Cancer, 1992, 28: 1692-1692

[13]

American Joint Committee Cancer. Manual for staging of cancer, 1988ed. 3PhiladelphiaJ B Lippincott143-143

[14]

TapiaF J, BarbosaA J A, MarangosP J, et al.. Neuron-specific enolase is produced by neuroendocrine tumors. Lacet, 1981, 1: 808-808

[15]

DhillonA P, RodeJ, LeathernA. Neuron specific enolase: an aid to the diagnosis of melanoma and neuroblastoma. Histopathology, 1982, 6: 81-81

[16]

RoydsJ A, ParsonsM A, ChampionA E. Plasma gammar-enolase as a marker for malignant melanoma. J Pathol, 1984, 142: 33A-33A

[17]

LorenzJ, DippoldW. Neuron-specific enolase: a serum marker for malignant melanoma. J Natl Cancer Inst, 1989, 81: 1754-1754

AI Summary AI Mindmap
PDF

224

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/